Aster DM Healthcare Shareholders Approve Gulf Business Spin-Off Deal

Aster DM Healthcare, a leading hospital chain, announced on Tuesday that its shareholders have approved the proposal to separate its Gulf business in a deal valued at USD 1.01 billion. The proposed resolutions were passed with an overwhelming majority by shareholders on January 22, with over 99% of the votes polled in favor of the deal, as per a regulatory filing by the company.

Representative image

Separation Plan

On November 28, 2022, Aster DM Healthcare unveiled its plan to separate its India and Gulf businesses through a transaction worth over USD 1 billion. The company received approval from its board and subsidiary, Affinity Holdings Pvt Ltd, to divide the India and GCC (Gulf Cooperation Council) operations into two distinct and independent entities.

Under the separation plan, Affinity entered into a definitive agreement with a consortium of investors led by Fajr Capital, a prominent private equity firm based in the UAE, to invest in Aster's GCC business. This separation aims to establish two distinct regional healthcare entities that can leverage strategic and financial flexibility to cater to growing market demand and prioritize patient needs.

Dedicated Management and Growth Potential

Both the India and GCC entities will operate with dedicated management teams and benefit from specialized investor bases that will support future growth in their respective markets. India holds significant growth potential for Aster, with a presence in five South Indian states through 19 hospitals, 13 clinics, 226 pharmacies, and 251 patient experience centers.

In the Gulf region, Aster operates an extensive network of 15 hospitals, 118 clinics, and 276 pharmacies across the United Arab Emirates, Saudi Arabia, Qatar, Oman, Bahrain, and Jordan, catering to the healthcare needs of the region.

Stock Performance

On the Bombay Stock Exchange (BSE), shares of Aster DM Healthcare experienced a decline of 1.99% on Tuesday, closing at Rs 425.20 per share.